International – Highly Capitalized

Wednesday, May 20, 2026 We Follow The Money.

UK Medical Cannabis H1 2025: The Market Still Running on Trust

HCN News Team2026-05-20T03:23:16-08:00May 20th, 2026|Business, Insights, International|

LONDON – You won't find the echoes of this revolution ...

Bioxyne Double-Strikes in LATAM and Europe

HCN News Team2026-05-15T04:46:10-08:00May 15th, 2026|Business, International|

SYDNEY – Bioxyne Limited, an international health and life sciences ...

Cannara Biotech Wraps Up Medican Organic Acquisition

HCN News Team2026-05-07T02:37:03-08:00May 7th, 2026|Business, International, M&As|

MONTREAL – Cannara Biotech Inc. announced the closing of a ...

High Tide Scores Big in Germany Through Remexian Distribution

HCN News Team2026-05-06T06:06:40-08:00May 6th, 2026|International|

CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German ...

Tilray Acquires Lyphe Group, Expands UK Medical Cannabis Reach

HCN News Team2026-04-16T04:48:27-08:00April 16th, 2026|International, M&As|

LONDON – Tilray Brands Inc. has acquired the Lyphe Group, ...

German Pharmacies Offer Cannabis Cheaper Than Darknet

HCN News Team2026-04-15T08:25:07-08:00April 15th, 2026|Insights, International|

BERLIN – Cannabis flower available by prescription through German pharmacies ...

Bioxyne to Manufacture Medical Cannabis Products for Aurora Cannabis

HCN News Team2026-04-08T04:54:49-08:00April 8th, 2026|Business, International|

SYDNEY – In a development that highlights the growing emphasis ...

Innocan Pharma Closes Additional Insider Debenture

HCN News Team2026-04-07T05:15:45-08:00April 7th, 2026|International|

HERZLIYA-CALGARY – Innocan Pharma Corp. announced that it had completed ...

India Awards First Public Funding for Cannabis Research in More Than 50 Years

HCN News Team2026-03-31T05:17:04-08:00March 31st, 2026|International|

NEW DELHI – The Indian government has awarded public funding ...

Tilray Medical Expands Australian Medical Cannabis Offerings

HCN News Team2026-03-19T08:37:27-08:00March 19th, 2026|International|

NEW YORK – Tilray Medical, an internal division of Tilray ...

DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

© Copyright | Highly Capitalized | All Rights Reserved | Website by Vadimages.